These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18837827)

  • 1. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
    Hendrickx G; Van Herck K; Vorsters A; Wiersma S; Shapiro C; Andrus JK; Ropero AM; Shouval D; Ward W; Van Damme P
    J Viral Hepat; 2008 Oct; 15 Suppl 2():1-15. PubMed ID: 18837827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral hepatitis A: when a changing epidemiology implies a different prophylaxis].
    Martet G; Morillon M; Debonne JM; Louis FJ
    Sante; 1998; 8(2):113-7. PubMed ID: 9642731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
    Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and control of hepatitis A.
    Maguire H; Heptonstall J; Begg NT
    Commun Dis Rep CDR Rev; 1992 Sep; 2(10):R114-7. PubMed ID: 1284926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A outbreaks--methods of intervention in South-East Asian countries.
    David AM;
    Int J Infect Dis; 2004 Jul; 8(4):201-9. PubMed ID: 15234323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH; Pan XJ; Wang XL
    Vaccine; 2008 Aug; 26(35):4608-16. PubMed ID: 18597903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress Toward Eliminating Hepatitis A Disease in the United States.
    Murphy TV; Denniston MM; Hill HA; McDonald M; Klevens MR; Elam-Evans LD; Nelson NP; Iskander J; Ward JD
    MMWR Suppl; 2016 Feb; 65(1):29-41. PubMed ID: 26916458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
    Al-Aziz AM; Awad MA
    East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and prevention of hepatitis A in travelers.
    Wu D; Guo CY
    J Travel Med; 2013; 20(6):394-9. PubMed ID: 24165384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
    Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
    Barkai G; Belmaker I; Givon-Lavi N; Dagan R
    Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing epidemiology of hepatitis A in Brazil: reassessing immunization policy.
    Vitral CL; Souto FJ; Gaspar AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():22-5. PubMed ID: 18837829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.